EP 4054625 A1 20220914 - ENDOTHELIAL LIPASE ANTIBODIES FOR THE TREATMENT OF CARDIOVASCULAR DISEASES
Title (en)
ENDOTHELIAL LIPASE ANTIBODIES FOR THE TREATMENT OF CARDIOVASCULAR DISEASES
Title (de)
ENDOTHELIALE LIPASE-ANTIKÖRPER ZUR BEHANDLUNG KARDIOVASKULÄRER ERKRANKUNGEN
Title (fr)
ANTICORPS DE LIPASE ENDOTHÉLIALE POUR LE TRAITEMENT DE MALADIES CARDIOVASCULAIRES
Publication
Application
Priority
- US 201962932257 P 20191107
- US 201962940164 P 20191125
- US 202063104410 P 20201022
- US 2020059458 W 20201106
Abstract (en)
[origin: WO2021092421A1] The present disclosure provides methods of administering antibodies and antigen-binding fragments thereof that specifically bind to human endothelial lipase (EL) to a subject in need thereof, for example, a subject with cardiovascular disease.
IPC 8 full level
A61K 39/00 (2006.01); A61K 9/08 (2006.01); A61K 39/395 (2006.01)
CPC (source: EP US)
A61K 9/0019 (2013.01 - EP US); A61P 9/10 (2017.12 - US); C07K 16/40 (2013.01 - EP US); A61K 2039/505 (2013.01 - EP); A61K 2039/507 (2013.01 - EP US); A61K 2039/545 (2013.01 - EP US); C07K 2317/24 (2013.01 - EP); C07K 2317/33 (2013.01 - EP US); C07K 2317/76 (2013.01 - EP US); C07K 2317/90 (2013.01 - EP)
Citation (search report)
See references of WO 2021092421A1
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
DOCDB simple family (publication)
WO 2021092421 A1 20210514; AU 2020378424 A1 20220623; CA 3192235 A1 20210514; CN 114650839 A 20220621; EP 4054625 A1 20220914; JP 2023501465 A 20230118; TW 202131951 A 20210901; US 2023045712 A1 20230209
DOCDB simple family (application)
US 2020059458 W 20201106; AU 2020378424 A 20201106; CA 3192235 A 20201106; CN 202080077755 A 20201106; EP 20885100 A 20201106; JP 2022526524 A 20201106; TW 109138910 A 20201106; US 202017775143 A 20201106